Navigation Links
Jubilant Biosys Launches Legend NGSS(TM) Advanced Software Solution for High-Throughput Drug Molecule Screening
Date:1/21/2009

p://www.jubilantbiosys.com" target="_new">http://www.jubilantbiosys.com), is a subsidiary of India-based Jubilant Organosys Ltd. It provides integrated drug discovery and development solutions to the global pharmaceutical industry. Jubilant Biosys has 125,000 sq. ft. state-of-the-art facility in Bangalore, India. The center houses more than 500 scientists specializing in Bioinformatics, in vitro, in vivo biology, HTS, medicinal chemistry, structural biology, pharmacology, molecular modeling, information technology, and other scientific disciplines. The company has expanded relationships with the global pharmaceutical industry across the drug discovery and development value chain.

Jubilant Organosys

Jubilant Organosys Ltd. is an integrated pharmaceutical industry player, the largest custom research and manufacturing services (CRAMS) and drug discovery and development services company out of India. The Company's consolidated sales in FY '07-08 stood at over US$ 600 million.


'/>"/>
SOURCE Jubilant Biosys
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Jubilant and BioLeap Announce New Partnership in Drug Discovery
2. SemBioSys announces senior management changes
3. Prosolia and Indigo BioSystems Come Together to Create FireFly(TM) Data Conversion Software for Mass Spectrometers
4. SemBioSys receives US$2.5 million from option agreement with MannKind for plant-produced insulin
5. Applied Biosystems SOLiD System Named Life Science Innovation of the Year : The Scientist Magazine Cites the Technology's High Throughput, Lower Sequencing Cost, and Rapid Technology Innovation for Unlocking New Approaches to Clinical Research
6. SemBioSys begins phase I/II trial of insulin produced in plant seeds
7. Cyprotex Purchases Applied Biosystems Sciex QTRAP(R) 5500 LC-MS/MS
8. Altogen Biosystems Launches New Nanoparticle-based In Vivo Transfection Reagent
9. Enigma Diagnostics Announces Patent Licence With Applied Biosystems
10. SemBioSys eligible to proceed with Phase I/II plant-produced insulin trial after submission of IND
11. SemBioSys announces second quarter 2008 financial and operational results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... July 03, 2015 , ... Cuvettes have been used in countless labs for decades. In ... cuvette they needed. As expected, this was a daunting and tiring process looking at ... they were not able to navigate the complex catalog structure. , Now thanks to FireflySci, ...
(Date:7/2/2015)... ... July 02, 2015 , ... Sleepless nights will become obsolete as ... sleep, launched its Indiegogo campaign on June 23. Sound sleepers and the sleep deprived ... it effortless to use, while the integration of the Bluetooth speaker, alarm clock and ...
(Date:7/1/2015)... , July 1, 2015   Decision Resources ... cited advantages of Otezla are its oral administration, ... as reported by surveyed rheumatologists. Otezla was the ... the treatment of active psoriatic arthritis in ... standard of care includes conventional oral treatments including ...
(Date:7/1/2015)... 1, 2015  Axovant Sciences Ltd. (NYSE:  AXON), ... treatment of dementia, today announced that the company ... at 5:45 p.m. EDT following its presentation of ... Conference 2015 (AAIC). The event ... Dr. Lawrence Friedhoff , Chief Development Officer, ...
Breaking Biology Technology:New Cuvette E-Commerce Website Launched by FireflySci 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 2Axovant Sciences To Host Investor Briefing And Live Webcast During AAIC 2015 Meeting 3
... This release is available in Spanish . ... have identified and characterized for the first time different antioxidant ... a medicinal herb called Teucrium polium. They have used two ... have enabled them to identify and quantify a great part ...
... , , FT. LAUDERDALE, ... Bulletin Board: ISPI) announced today an important development within the ... technology of Integral Bioenergies Systems, SL (IBS). This firm has ... treatment of biomass/sludge obtained at sewage treatment plants. , IBS ...
... , , LONDON and ... Silence Therapeutics plc (AIM: SLN) today announced that Philip Haworth ... update at the 12th Annual BIO CEO & Investor Conference.  The conference ... in New York City . , Silence,s presentation will take place ...
Cached Biology Technology:New antioxidant compounds have been identified in foods such as olive oil, honey and nuts 2InfoSpi Shall Benefit From Contract for Future Use of IBS Technology 2Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference 2Silence Therapeutics to Present at 12th Annual BIO CEO & Investor Conference 3
(Date:6/16/2015)... -- With the increasing number and severity of data breaches ... recent compromise of Federal employee data from OPM,s ... government agencies. HYPR Corp. announced today that ... has been submitted for testing and approval of Federal ... tamper proofing. The proliferation of security ...
(Date:6/15/2015)... A new report [ 1 ] ... consumers using mobile banking applications want their mobile devices to ... instead of having to prove who they are with passwords ...   -   The Fusion of Financial Services, Mobile and ... channel used by Gen X and Gen Y to access ...
(Date:6/10/2015)... 2015 According to a ... Technology (Ultrasound, TOF, Structured Light, Stereo Vision), Type(Image, ... and by Geography - Trends & Forecast to ... is expected to reach $3,319.71 Million by 2020, ... and 2020. Browse 71 market data ...
Breaking Biology News(10 mins):Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 2One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 3One in Four US Consumers Would Share Their DNA With Their Bank to Secure Financial and Personal Information, Telstra Report Finds 43D Sensor Market Worth $3,319.71 Million by 2020 23D Sensor Market Worth $3,319.71 Million by 2020 33D Sensor Market Worth $3,319.71 Million by 2020 4
... Wiley Interdisciplinary Reviews (WIREs), the pioneering new publications launched ... the most prestigious awards in scholarly publishing at the ... Professional & Scholarly Excellence (PROSE Awards) named the WIREs ... the association,s top prize, established in 1976 to recognise ...
... of Medicine believe they may have discovered how the ... The findings will be presented at the Annual Scientific ... Chicago by Errol Norwitz, M.D., professor in the Department ... Preterm birthdelivery prior to 37 weeks gestationhas become ...
... Eastern Illinois Foodbank shared results of a national study ... organization. The study is completed every four years by ... emergency food distribution throughout the United States. Craig Gundersen, ... Consumer Economics at the University of Illinois, is a ...
Cached Biology News:WIREs win 3 prizes at the PROSE awards 2U of I faculty assist in evaluating US food security programs 2
Request Info...
Agarose-LE, 500 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Request Info...
Biology Products: